AI assistant
SURMODICS INC — Director's Dealing 2018
Aug 14, 2018
32845_dirs_2018-08-14_91f4614f-8f98-4a2d-b5e4-88b72615ff92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-08-10
Reporting Person: Stich Joseph J. (VP and GM, IVD)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-10 | Common Stock | S | 100 | $67.30 | Disposed | 53819 | Direct |
| 2018-08-10 | Common Stock | S | 200 | $68.425 | Disposed | 53619 | Direct |
| 2018-08-10 | Common Stock | S | 1700 | $70.0596 | Disposed | 51919 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
F2: Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 10, 2018 with sale prices ranging from $68.40 to $68.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 1,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 10, 2018 with sale prices ranging from $69.55 to $70.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.